Sitagliptin (50mg) + Metformin (500mg)
Active composition
+1 more active ingredient
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
SITARAY M 50/500MG TAB is an advanced, dual-action oral anti-diabetic combination medication containing Sitagliptin (50 mg) and Metformin (500 mg). It is primarily prescribed for the management of Type 2 Diabetes Mellitus when diet, exercise, and single-drug therapy are insufficient to control blood sugar levels. Sitagliptin belongs to the DPP-4 inhibitor class; it works by increasing the levels of incretin hormones, which stimulate the pancreas to produce more insulin and signal the liver to stop producing excess sugar. Metformin, a biguanide, works by lowering glucose production in the liver, delaying glucose absorption from the intestines, and increasing the body's sensitivity to its own insulin. Together, they provide highly effective, complementary glycemic control and help prevent long-term diabetic complications affecting the kidneys, eyes, and nerves.
Swallow the tablet whole with a glass of water. Do not crush, chew, or break it. This medicine must be taken with or immediately after meals (usually twice daily, or as prescribed). Taking it with food significantly reduces the risk of common gastrointestinal side effects like stomach upset, nausea, or diarrhea caused by Metformin. Take it consistently at the same times every day. Never stop taking this medication abruptly without consulting your doctor, even if your blood sugar readings normalize.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Unsaffe. Avoid alcohol completely. Mixing alcohol with Metformin drastically increases the risk of Lactic Acidosis—a rare but life-threatening metabolic complication. It can also cause unpredictable blood sugar crashes (hypoglycemia).
High Risk
Unsafe. It is generally not recommended during pregnancy. Insulin is typically the preferred and safest choice for controlling blood sugar during gestational or pre-existing diabetes. Consult your doctor immediately if you plan to conceive.
Medical Advice
Safe. On its own, this medicine does not cause drowsiness or hypoglycemia. However, if taken alongside other anti-diabetic drugs (like sulfonylureas or insulin), your blood sugar could drop, causing dizziness. Keep a fast-acting sugar source handy.
Exercise Caution
Caution. It should be used with extreme caution or avoided in patients with severe, active liver disease, as hepatic impairment compromises the body's ability to clear lactate, further increasing the risk of lactic acidosis.
Regular Checkup
Caution. Metformin can pass into breast milk in small amounts, and data on Sitagliptin during lactation is limited. Consult your physician, who will weigh the benefits against potential risks to the infant.
Consult Doctor
Caution. Metformin is cleared exclusively by the kidneys. If you have severe kidney impairment (low eGFR levels), this drug is contraindicated due to the high risk of lactic acidosis. Regular kidney function tests (eGFR/Serum Creatinine) are mandatory.
Regular Checkup
0 reviews for SITARAY M 50/500MG TAB
Sitagliptin 50 mg + Metformin 500 mg
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Sitagliptin inhibits DPP-4, increasing incretin levels, which stimulate insulin release and reduce glucagon secretion.
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Medical applications
SITARAY M 50/500MG TAB is an advanced, dual-action oral anti-diabetic combination medication containing Sitagliptin (50 mg) and Metformin (500 mg). It is primarily prescribed for the management of Type 2 Diabetes Mellitus when diet, exercise, and single-drug therapy are insufficient to control blood sugar levels. Sitagliptin belongs to the DPP-4 inhibitor class; it works by increasing the levels of incretin hormones, which stimulate the pancreas to produce more insulin and signal the liver to stop producing excess sugar. Metformin, a biguanide, works by lowering glucose production in the liver, delaying glucose absorption from the intestines, and increasing the body's sensitivity to its own insulin. Together, they provide highly effective, complementary glycemic control and help prevent long-term diabetic complications affecting the kidneys, eyes, and nerves.
Swallow the tablet whole with a glass of water. Do not crush, chew, or break it. This medicine must be taken with or immediately after meals (usually twice daily, or as prescribed). Taking it with food significantly reduces the risk of common gastrointestinal side effects like stomach upset, nausea, or diarrhea caused by Metformin. Take it consistently at the same times every day. Never stop taking this medication abruptly without consulting your doctor, even if your blood sugar readings normalize.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Unsaffe. Avoid alcohol completely. Mixing alcohol with Metformin drastically increases the risk of Lactic Acidosis—a rare but life-threatening metabolic complication. It can also cause unpredictable blood sugar crashes (hypoglycemia).
High Risk
Unsafe. It is generally not recommended during pregnancy. Insulin is typically the preferred and safest choice for controlling blood sugar during gestational or pre-existing diabetes. Consult your doctor immediately if you plan to conceive.
Medical Advice
Safe. On its own, this medicine does not cause drowsiness or hypoglycemia. However, if taken alongside other anti-diabetic drugs (like sulfonylureas or insulin), your blood sugar could drop, causing dizziness. Keep a fast-acting sugar source handy.
Exercise Caution
Caution. It should be used with extreme caution or avoided in patients with severe, active liver disease, as hepatic impairment compromises the body's ability to clear lactate, further increasing the risk of lactic acidosis.
Regular Checkup
Caution. Metformin can pass into breast milk in small amounts, and data on Sitagliptin during lactation is limited. Consult your physician, who will weigh the benefits against potential risks to the infant.
Consult Doctor
Caution. Metformin is cleared exclusively by the kidneys. If you have severe kidney impairment (low eGFR levels), this drug is contraindicated due to the high risk of lactic acidosis. Regular kidney function tests (eGFR/Serum Creatinine) are mandatory.
Regular Checkup
0 reviews for SITARAY M 50/500MG TAB















